MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
261.51%
Quick Ratio
248.49%
Cash Ratio
27.28%
Debt to Asset Ratio
20.75%
Unit: Thousand (K) dollars
Assets Breakdown
    • Deferred income tax asset
    • Short-term investments
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Loans payable, net, current port...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
24,411 40,580 48,534 53,407
Short-term investments
122,273 114,375 88,609 54,972
Accounts receivable, net
49,945 51,763 45,925 39,907
Inventories
11,652 11,506 13,303 10,423
Prepaid and other current assets
25,746 21,942 18,556 16,684
Total current assets
234,027 240,166 214,927 175,393
Property and equipment, net
NaN NaN 54 57
Intangible assets, net
24,160 24,748 25,336 25,924
Deferred income tax asset
243,279 245,852 NaN NaN
Operating lease right-of-use assets
785 920 1,050 1,178
Other assets
2,357 1,908 1,167 4,184
Total assets
504,608 513,594 242,534 206,736
Accounts payable
4,486 7,191 3,846 7,290
Accrued compensation
6,009 11,914 10,065 7,897
Deferred revenue
NaN NaN 1,355 1,355
Accrued research and development
5,742 5,524 4,816 4,121
Acquisition-related liabilities
5,000 5,000 5,000 5,000
Revenue reserves and refund liability
28,080 27,716 30,020 29,502
Loans payable, net, current portion
29,865 29,812 29,761 22,361
Other current liabilities
NaN 11,466 NaN NaN
Other accrued liabilities
9,674 NaN 8,943 8,593
Lease liabilities, current portion
636 614 594 517
Total current liabilities
89,492 99,237 94,400 86,636
Acquisition-related liabilities
NaN 0 NaN NaN
Long-term portion of lease liabilities
228 395 556 714
Long-term portion of loans payable, net
14,991 22,482 29,969 37,452
Other long-term liabilities
NaN 0 NaN NaN
Total liabilities
104,711 122,114 124,925 124,802
Common stock
18 18 18 18
Additional paid-in capital
1,414,394 1,414,322 1,408,601 1,400,916
Accumulated other comprehensive (loss) income
-128 181 96 6
Accumulated deficit
-1,014,387 -1,023,041 -1,291,106 -1,319,006
Total stockholders equity
399,897 391,480 117,609 81,934
Total liabilities and stockholders equity
504,608 513,594 242,534 206,736
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$122,273K Accounts receivable, net$49,945K Prepaid and othercurrent assets$25,746K Cash and cashequivalents$24,411K Inventories$11,652K Deferred income tax asset$243,279K Total current assets$234,027K Intangible assets, net$24,160K Other assets$2,357K Operating leaseright-of-use assets$785K Total assets$504,608K Total liabilities andstockholders equity$504,608K Total stockholdersequity$399,897K Total liabilities$104,711K Accumulated deficit-$1,014,387K Accumulated othercomprehensive (loss) income-$128K Additional paid-in capital$1,414,394K Total currentliabilities$89,492K Long-term portion of loanspayable, net$14,991K Long-term portion of leaseliabilities$228K Common stock$18K Loans payable, net,current portion$29,865K Revenue reserves andrefund liability$28,080K Other accruedliabilities$9,674K Accrued compensation$6,009K Accrued research anddevelopment$5,742K Acquisition-related liabilities$5,000K Accounts payable$4,486K Lease liabilities,current portion$636K

RIGEL PHARMACEUTICALS INC (RIGL)

RIGEL PHARMACEUTICALS INC (RIGL)